Somatic human ZBTB7A zinc finger mutations promote cancer progression

X-S Liu1,2, Z Liu3, C Gerarduzzi1

  • 1Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA, USA.

Oncogene
|October 13, 2015
PubMed

Insights

Loss-of-function mutations in ZBTB7A, a gene repressing glycolysis, drive cancer by increasing tumor metabolism. This discovery offers new therapeutic targets for cancers with ZBTB7A mutations.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metabolism

Background:

  • ZBTB7A acts as a transcription repressor for key glycolytic genes.
  • Downregulation of ZBTB7A is linked to altered tumor metabolism in human cancers.
  • Reduced ZBTB7A expression is observed in a subset of human cancers, prompting investigation into alternative inactivation mechanisms.

Purpose of the Study:

  • To identify alternative mechanisms of ZBTB7A inactivation in human cancers.
  • To investigate the functional consequences of ZBTB7A mutations.
  • To explore the role of ZBTB7A loss-of-function in cancer metabolism and proliferation.

Main Methods:

  • Mining human cancer genome databases for ZBTB7A mutations.
  • Functional characterization of ZBTB7A mutants, particularly those in the zinc finger domain.
  • Analysis of glycolytic gene expression, glycolysis rates, and cell proliferation in cancer cells with ZBTB7A mutations.

Main Results:

  • Recurrent somatic mutations in ZBTB7A were identified across multiple human cancer types.
  • Mutations were significantly enriched within the zinc finger domain of ZBTB7A.
  • Zinc finger mutations led to a complete loss of ZBTB7A function.
  • Upregulation of glycolytic genes, increased glycolysis, and enhanced proliferation were observed in cancer cells with ZBTB7A zinc finger mutations.

Conclusions:

  • Loss-of-function mutations in ZBTB7A represent a novel mechanism driving elevated glycolysis in human cancer.
  • ZBTB7A mutations, particularly in the zinc finger domain, contribute to tumorigenesis by promoting Warburg-like metabolism.
  • Targeting ZBTB7A inactivation pathways may offer new therapeutic strategies for specific cancer types.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression02:07

Tumor Progression

3.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.5K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

3.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K